Why the study?
Does digoxin at low serum concentrations reduce mortality in systolic and diastolic heart failure?
Does digoxin at low serum concentrations reduce mortality in systolic and diastolic heart failure?
Answers are grounded in this paper and cite their sources.
Discusses the findings of Ahmed et al. regarding the potential mortality benefits of low serum digoxin concentrations in heart failure.
The DIG trial is the largest trial of digoxin and a very important trial that is not likely to be replicated soon. Therefore, the analyses of Ahmed et al .1 is useful and welcomed.
No takes yet. Share an insight, caveat, or question.
Shahbudin H. Rahimtoola (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: